| Category | Key findings | Key citations (with year) | URLs when available |
|---|---|---|---|
| Identity/topology | Human ENPP4 corresponds to UniProt Q9Y6X5 and is an ENPP-family ectonucleotide pyrophosphatase/phosphodiesterase. It is placed in the ENPP4–7 subgroup, described as a type I single-pass membrane protein with the signature phosphodiesterase (PDE) domain; Imam 2024 also localizes its proposed activity to the endothelial cell surface, consistent with extracellular/membrane-associated function. (pqac-00000003, pqac-00000008, pqac-00000001) | Borza et al., 2022; Imam et al., 2024 | https://doi.org/10.1016/j.jbc.2021.101526 ; https://doi.org/10.3390/metabo14120659 |
| Catalytic mechanism | ENPP4 is inferred to use the canonical ENPP catalytic machinery: a shallow PDE active site with two catalytic Zn2+ ions and a catalytic threonine nucleophile. The family mechanism proceeds via nucleophilic attack on the phosphodiester bond, formation of an enzyme-product intermediate, and hydrolysis by water. (pqac-00000007, pqac-00000008) | Borza et al., 2022 | https://doi.org/10.1016/j.jbc.2021.101526 |
| Substrates/products | Best-supported substrate annotation is diadenosine polyphosphate hydrolysis. Imam 2024 summarizes ENPP4 as hydrolyzing Ap3A to ADP + AMP and Ap4A to ATP + AMP; Borza 2022 states ATP and Ap3A are substrates in vitro, but ATP hydrolysis is negligible compared with ENPP1, whereas Ap3A hydrolysis is comparable to ENPP1/ENPP2. Overall, ENPP4 is best viewed as an Ap3A/AP4A hydrolase rather than a major ATPase. (pqac-00000005, pqac-00000007, pqac-00000011) | Borza et al., 2022; Imam et al., 2024 | https://doi.org/10.1016/j.jbc.2021.101526 ; https://doi.org/10.3390/metabo14120659 |
| Structures | Available structures/models are reported for human ENPP4, including PDB 4LQY (Borza 2022) and a human ENPP4 structure cited in Imam 2024 alongside AlphaFold model AF-Q9Y6X5. Imam 2024 further notes that ENPP4 structures do not show an AP-like dimeric interface, unlike some other family members. (pqac-00000006, pqac-00000008) | Borza et al., 2022; Imam et al., 2024 | https://doi.org/10.1016/j.jbc.2021.101526 ; https://doi.org/10.3390/metabo14120659 |
| Proposed biological role | Current expert synthesis proposes that endothelial-surface ENPP4 hydrolyzes Ap3A/Ap4A to generate ADP locally, promoting platelet activation/degranulation through P2Y1/P2Y12 signaling. Borza 2022 states ENPP4 promotes platelet aggregation in human plasma via ADP production, but also notes that in vivo confirmation (e.g., knockout models) is still needed. (pqac-00000001, pqac-00000009, pqac-00000011) | Borza et al., 2022; Imam et al., 2024 | https://doi.org/10.1016/j.jbc.2021.101526 ; https://doi.org/10.3390/metabo14120659 |
| Disease/omics associations | Open Targets lists ENPP4 disease associations derived mainly from GWAS credible sets rather than mechanistic studies. Reported disease-level scores include COVID-19/severe acute respiratory syndrome 0.2987, tooth disease 0.2624, temporomandibular joint disorder 0.2494, and mental or behavioural disorder 0.1047, with four evidence entries tied to PMIDs 36662838 and 39024449. These associations are hypothesis-generating and do not establish causal ENPP4 function. (pqac-00000010) | Open Targets Platform query (current platform evidence) | https://platform.opentargets.org/target/ENSG00000001561 |
| Evidence strength | Identity, family assignment, membrane topology, catalytic mechanism, and structural placement are supported by authoritative expert reviews. Substrate preference for Ap3A/Ap4A has moderate support from biochemical/structural synthesis. Biological role in platelet activation is plausible and supported by plasma-based evidence but remains incompletely validated in vivo. Disease links from Open Targets are currently low-to-moderate confidence genetic/omics associations rather than direct functional annotation. (pqac-00000005, pqac-00000007, pqac-00000009, pqac-00000010) | Borza et al., 2022; Imam et al., 2024; Open Targets | https://doi.org/10.1016/j.jbc.2021.101526 ; https://doi.org/10.3390/metabo14120659 ; https://platform.opentargets.org/target/ENSG00000001561 |


*Table: This table summarizes the current functional annotation of human ENPP4 (Q9Y6X5), integrating expert reviews and platform evidence on topology, catalytic mechanism, substrate specificity, structures, biological role, and disease associations. It is useful as a concise evidence map distinguishing well-supported facts from still-provisional inferences.*